The Cancer Prevention Research Institute of Texas (CPRIT) has awarded nearly $1.2 million to Dr. James Brugarolas, founding Director of the Kidney Cancer Program at UTSW. This funding will support his research into translocation renal cell carcinoma (tRCC), a rare and aggressive form of kidney cancer that primarily affects children and young adults.
tRCC remains poorly understood due to its rarity, and a lack of suitable models has hindered progress in developing effective treatments. The Brugarolas Lab recently developed a mouse model that replicates the human disease, providing a critical tool for further study. With this CPRIT grant, they will conduct mechanistic studies using the UTSW transgenic mouse core, led by Dr. Robert Hammer, and collaborate with Dr. Ben Sabari to explore potential drug therapies.
This research could lead to key insights into tRCC biology and lay the foundation for new treatment strategies, offering hope for patients with this challenging disease.
Read more about the award here.